Molecular Devices products to be supplied and serviced by Bio-Strategy
After 1 June, Molecular Devices products (previously supplied by MDS Analytical Technologies) will be supplied, serviced and supported by Bio-Strategy in both Australia and New Zealand.
Most of MDS Analytical Technologies' Australian employees have joined Bio-Strategy, and instrument warranties and ongoing service agreements have also been transferred to Bio-Strategy.
For any concerns or questions regarding this transition, Bio-Strategy can be contacted on:
Free phone: 1800 00 84 53
Email: info@bio-strategy.com
Web: www.bio-strategy.com
ACRF funds three new cancer research facilities
Scientists at QIMR Berghofer, the Peter MacCallum Cancer Centre and the Bio21 Institute have...
Govt announces $1.89bn package for health and medical research
The Australian Government is investing in a "once-in-a-generation transformation of health...
Accreditation Matters announces further speakers, MC
Respected journalist and presenter Steve Liebmann has been confirmed as host and MC for the...
